RCM
SBCWW

Radcliffe Capital Management’s SBC Medical Group Warrants SBCWW Stock Holding History

Radcliffe Capital Management’s Portfolio SBCWW Stock Details SBCWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-300,000
Closed -$14.3K – 255
2023
Q3 		$14.3K Hold
300,000
– – ﹤0.01% 304
2023
Q2 		$16.8K Hold
300,000
– – ﹤0.01% 356
2023
Q1 		$16.1K Hold
300,000
– – ﹤0.01% 457
2022
Q4 		$3.06M Buy
+300,000
New +$13.9K 0.1% 336

Other funds holding SBCWW

MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
TCA
Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Radcliffe Capital Management's SBCWW Position: Q4 2023 in Review

Radcliffe Capital Management sold out of SBC Medical Group Warrants (SBCWW) in Q4 2023, closing a stake of 300,000 shares — an estimated $14.3K sold.

Radcliffe Capital Management first reported a position in SBCWW in Q4 2022 and held it in 4 quarters. The position peaked at $3.06M in Q4 2022. 31 funds tracked by Wall St. Rank hold SBCWW as of Q4 2023.

  • Radcliffe Capital Management reported no remaining SBC Medical Group Warrants position as of Q4 2023 after selling out during the quarter.
  • Radcliffe Capital Management sold 300,000 SBC Medical Group Warrants shares in Q4 2023, an estimated $14.3K.
  • Radcliffe Capital Management first reported a position in SBC Medical Group Warrants in Q4 2022 and held it in 4 quarters.
  • Radcliffe Capital Management's SBC Medical Group Warrants position peaked at $3.06M in Q4 2022.
  • 31 funds tracked by Wall St. Rank held SBC Medical Group Warrants as of Q4 2023.

Based on Radcliffe Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.